ACT Biotech Files Special Protocol Assessment With FDA for Phase 3 Trial of Telatinib for Front-Line Treatment of Stomach Cancer SAN FRANCISCO, Feb. 28, 2011 (GLOBE NEWSWIRE) -- ACT Biotech, Inc., a biopharmaceutical company focused on the development of highly targeted, oral therapeutics for the treatment of cancer, announced...

Lahey Clinic Medical Center is Latest Hospital to Select Mediware's MediMAR and MediCOE Solutions LENEXA, Kan., Jan. 31, 2006 (PRIMEZONE) -- Mediware Information Systems (Nasdaq:MEDW) today announced that Lahey Clinic Medical Center of Burlington, MA., will expand its long-term relationship with...